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SUMMARY 
Babesiosis is a protozoan disease caused by Babesia spp, which is an intra-erythrocytic parasite of 
domestic and wild animals. The parasite is mainly transmitted by infected ticks through bite and it 
is characterized by fever, paleness and icteric mucous membranes and emaciation. This paper 
reports case of babesiosis in a 3-month-old Nigerian indigenous male puppy at Veterinary Teaching 
Hospital, Ahmadu Bello University, Zaria. The relevant history, clinical signs and laboratory 
evaluations were recorded. The effects on some hematological parameters were studied and 
recorded. The dog was successfully transfused with 226 ml of blood and then treated with a single 
dose of 4% Diminazene aceturate at the dose rate of 4 mg/kg intramuscularly (I.M). Thereafter, the 
patient was monitored until fully recovered.   
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INTRODUCTION                                            
Babesia spp are tick-borne blood protozoan 
parasites that infect the erythrocytes of domestic 
and wild animals and humans. The distribution of 
canine babesiosis is worldwide and different 
species of Babesia have been described in dogs 
(Irwin, 2009; Solano-Gallego and Baneth, 2011). 
The clinical manifestations of the disease may 
vary with species, and strains, virulence, as well 
as other factors that determine the host's response 
to infection such as age, immune status, and the 
presence of concurrent infections (Jacobson, 
2006; Irwin, 2009).  
The disease onset is often acute with affected 
dogs suffering from fever and lethargy, and 
thereafter may display clinical manifestations of 
anemia, icterus and hemoglobinuria (Jacobson 
2006; Irwin, 2009; Eichenberger et al., 2016). 
The parasite can be identified under the 
microscope by its morphologic appearance in the 
erythrocytes, where large forms are designated 
Babesia canis, whereas small forms are 
designated to be Babesia gibsoni  (Schetters et 
al., 1997; Solano-Gallego and Baneth, 2011). 
Several drugs and drug combinations have been 
reported to be effective against canine babesiosis 
(Irwin 2009, Solano-Gallego and Baneth, 2011; 
Beugnet and Moreau, 2015). A single 
intramuscular injection of Diminazene aceturate 
(Azidin®, Berenil®, Ganasag®) at a dose of  3.5 




mg/kg IM once (Plumb, 2015) or 5 mg/kg 
(Birkenheuer et al., 1999; Taboada, 1998) or 
Imidocarb dipropionate (Imizol®, Carbesia®) 
with a labeled dose of  is 6.6 mg/kg 
intramuscularly (IM) or subcutaneously (SC) 
with a repeated dose in 2 weeks as approved by 
the Food and Drug Administration (FDA) 
(Conrad et al., 1991 and Checa et al., 2017).  
Supportive therapy such as intravenous fluids 
and blood transfusions are employed when 
necessary (Birkenheuer et al., 1999).  
CASE REPORT  
Case History 
A 3-month-old Nigerian indigenous male puppy 
weighing 6 kg was presented to the Small 
Animal Clinic of the Veterinary Teaching 
Hospital, Ahmadu Bello University Zaria, with 
the complaints of general weakness and off feed. 
History revealed that the puppy was first noticed 
to be off-feed 3 days prior to presentation. The 
puppy was dewormed by the client two days 
earlier with a quarter of fenbendazole tablet 
(unknown concentration). The puppy had not 
received any vaccination. 
RESULTS AND DISCUSSION  
On clinical examination, the patient’s vital 
parameters were:- temperature 39.6 0C, pulse rate 
168 beats/minute and respiratory rate 32 
cycles/minute. Other clinical findings were; 
bilateral muco-purulent ocular discharges, icteric 
ocular and oral mucous membranes, icteric skin 
discoloration around the inguinal region, pinna, 
and inter-digital spaces.  Furthermore, increased 
capillary refill time (10 secs), bilaterally enlarged 
superficial lymph nodes (sub-mandibular, pre-
scapular, and popliteal), 6% dehydration (dry 
muzzle and increased skin tenting), shallow 
breathing, lethargy, lateral recumbency (Plate 1) 
and yellowish-green urine obtained via 
cystocentesis (foamy upon vortex) were also 
observed. Based on the clinical signs observed, a 
tentative diagnosis of canine babesiosis was 
made. To further the diagnosis, blood samples 
were collected for hemo-parasite screening and a 
complete blood cell count. The collected urine 
sample was also sent for urinalysis. 
 
Plate 1: Recumbent and lethargic puppy 
under blood transfusion 
The hematological analysis revealed severe 
anemia (PCV-7 %) with marked polychromatic 
cells and anisocytosis. Leucocytosis due to 
neutrophilia was also observed (Table I). The 
urinalysis result revealed mild proteinuria and 
marked bilirubinuria. Babesia parasites +3 were 
seen on thin blood smear (Plate 2).  
 






Plate 2: Microscopic view of the Babesia 
parasite (arrow) in the RBC on thin blood 
smear 
A decision to conduct blood transfusion was 
taken because of the severe anaemia. For this 
purpose, another Nigerian indigenous dog was 
sourced to serve as the donor dog. After the dog 
was physically examined and ascertained to be 
clinically healthy blood and fecal samples were 
collected to screen for hemoparasites and 
gastrointestinal parasites. The dog tested 
negative for parasites for both of the samples 
screened. Moreover, the PCV of the dog was 
also determined and ascertained to be adequate 
for blood donation. The volume of blood 
required for the transfusion was calculated based 
on the formula given by Sackmen (1998): 
 
Consequently, 226 ml of blood was collected 
through the jugular vein of the donor dog in a 
blood bag and transfused to the puppy via the 
cephalic vein with the intention of raising its 
PCV to 18 %. During the course of blood 
transfusion to the patient, 4 % Diminazene 
diaceturate injection (4 mg/kg, I.M, once) was 
given. In addition, Vitamin B-complex injection 
(0.1 ml/kg, I.M) for five days was also given. 
The onset of canine babesiosis is often acute 
with affected dogs suffering from fever, lethargy, 
and thereafter may display clinical 
manifestations of  anemia, icterus and 
hemoglobinuria  (Jacobson 2006; Irwin, 2009; 
Eichenberger et al., 2016). 
TABLE I: Haemogram of the patient on the 
first day of presentation 
Parameters                          Patient’s              Reference  
                                            Values                values 
RBC (1012/L)                            1.0                  5.0-10.0 
HB(g/dl)                                  2.3                 12.0-18.0 
PCV (%)                                 7.0                   37-55 
WBC (109/L)                           18.4                 6-17 
NEUTROPHILS (109/L)           14.72               3.0-11.5 
LYMPHOCYTES (109/L)         3.31                 1.0-4.8 
EOSINOPHILS (109/L)            0.36                0.1-1.25 
TOTAL PROTEIN (g/dl)          5.6                  5.4-7.7 
TABLE II:  Haemogram of the patient a day 
after Transfusion 
Parameters                          Patient’s           Reference  
                                            values               values   
RBC (1012/L)                         5.0                   5.0-10.0 
HB(g/dl)                                10.6                 12.0-18.0 
PCV (%)                                32                   37-55 
WBC (109/L)                          15.1                 6-17 
NEUTROPHILS (109/L)           11.32               3.0-11.5 
LYMPHOCYTES (109/L)         3.47                 1.0-4.8 
EOSINOPHILS (109/L)             0.30                0.1-1.25 
Blood volume to be infused (ml) = Body weight (kg) × 90 × (Required PCV - Recipient’s PCV) 
                                                                     (Donor’s PCV)  




Plate 3: Microscopic view of the RBC two 
days after treatment 
TABLE III:  Haemogram of the patient a day 
after Transfusion  
Parameters                        Patient’s        Reference 
                                           Value           values 
RBC (1012/L)                         5.0            5.0-10.0 
HB(g/dl)                               10.6          12.0-18.0 
PCV (%)                               32             37-55 
WBC (109/L)                         15.1           6-17 
NEUTROPHILS (109/L)         11.32         3.0-11.5 
LYMPHOCYTES (109/L)       3.47           1.0-4.8 
EOSINOPHILS (109/L)          0.30           0.1-1.25 
Interpretation: Anisocytosis 
 
TABLE IV: Haemogram of the patient on day 
4 of re-presentation 
Parameters                        Patient’s        Reference  
                                           Values            values 
RBC (1012/L)                         4.7                5.0-10.0 
HB(g/dl)                                10.3               2.0-18.0 
PCV (%)                               31                  37-55 
WBC (109/L)                         13.5                6-17 
NEUTROPHILS (109/L)         8.77                3.0-11.5 
LYMPHOCYTES (109/L)        3.10               1.0-4.8 
EOSINOPHILS (109/L)          1.08                0.1-1.25 
Interpretation: Anaemia. 
The disease diagnosed here was acute given the 
onset (3 days) of clinical sign of anorexia as 
reported by the client. The parasitized 
erythrocytes were hemolysed at a very fast rate 
and hence the paleness of the mucous 
membranes and the icterus as a result of 
buildup of the conjugated bilirubin in 
the plasma. This was reported by 
Abdullahi et al., (1990) in Nigerian 
indigenous dogs naturally infected with 
Babesia spp.  









Interpretation: Normal leukogram with moderate   
                           anemia.    
 
Similar observation was also reported by Cunha 
et al., (2011) and Kanwarpal et al., (2020). The 
low PCV and bilirubinuria seen in the hemogram 
and the urinalysis result further confirmed the 
anemia and icterus respectively. Marked 
polychromatic cells (cells of different staining 
characteristics) and anisocytosis (cells of 
different sizes) observed were suggestive of a 
significant bone marrow response.  
Supportive therapy such as intravenous fluids 
and blood transfusions had been advocated 
during acute babesiosis (Birkenheuer et al., 
1999). The 7 % packed cell volume recorded 
TABLE V: Haemogram of the patient on 
day 5 of re- presentation 
Parameters                          Patient’s      Reference  
                                          values          values 
RBC (1012/L)                         4.0            5.0-10.0 
HB(g/dl)                                  8.6          12.0-18.0 
PCV (%)                               26               37-55 
WBC (109/L)                          10.0            6-17 
NEUTROPHILS (109/L)          6.1             3.0-11.5 
LYMPHOCYTES (109/L)         3.7             1.0-4.8 
EOSINOPHILS (109/L)            0.1             0 .1-1.25 




upon the first presentation of the puppy was too 
low that blood transfusion was indispensable. 
Moreover, Kanwarpal et al., (2020) reported that 
blood transfusion had remarkably improved the 
prognosis of the disease in a Labrador dog. 
Twenty four hours post transfusion the PCV 
increased to 32 % (Table III). However, 
subsequent sampling indicated a progressive 
decrease in the PCV which could probably be 
due to continuous clearance of the parasitized 
RBC from circulation which is expected to affect 
the overall PCV of the patient.   
Babesia canis treatment with Diminazene 
aceturate only or in combination with Imidocarb 
dipropionate had been demonstrated to be an 
effective treatment options (Beugnet et al., 2014) 
However, there use are associated with some 
complications such as pain at the injection site, 
hepato-renal impairment but in this case, none of 
such was seen.  
CONCLUSION AND RECOMMENDATION  
The role of blood transfusion in canine 
babesiosis has proved to be vital and possibly the 
game changer in determining the prognosis of 
this case. We therefore, recommend that the 
decision to undertake blood transfusion in cases 
of babesiosis presenting with a very low PCV 
should not be delayed as that is critical in 
determining the prognosis of the disease.  
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